Vigil Neuroscience, Inc. (VIGL)

$4.25

+0.26

(+6.52%)

Market is closed - opens 7 PM, 25 Jul 2024

Performance

  • $4.00
    $4.43
    $4.25
    downward going graph

    5.88%

    Downside

    Day's Volatility :9.7%

    Upside

    4.06%

    downward going graph
  • $2.47
    $9.24
    $4.25
    downward going graph

    41.88%

    Downside

    52 Weeks Volatility :73.27%

    Upside

    54.0%

    downward going graph

Returns

PeriodVigil Neuroscience, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
44.04%
5.5%
0.0%
6 Months
26.67%
7.2%
0.0%
1 Year
-46.44%
9.3%
0.0%
3 Years
-68.46%
13.0%
-19.9%

Highlights

Market Capitalization
147.0M
Book Value
$2.76
Earnings Per Share (EPS)
-2.12
Wall Street Target Price
16.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-35.24%
Return On Equity TTM
-60.18%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
0.0
EBITDA
-89.1M
Diluted Eps TTM
-2.12
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.93
EPS Estimate Next Year
-1.9
EPS Estimate Current Quarter
-0.61
EPS Estimate Next Quarter
-0.55

Analyst Recommendation

Buy
    85%Buy
    7%Hold
    7%Sell
Based on 14 Wall street analysts offering stock ratings for Vigil Neuroscience, Inc.(by analysts ranked 0 to 5 stars)
Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
12
12
12
Hold
1
1
1
Sell
1
1
1

Analyst Forecast

What analysts predicted

Upside of 276.47%

Current $4.25
Target $16.00

Technicals Summary

Sell

Neutral

Buy

Vigil Neuroscience, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc.
2.84%
26.67%
-46.44%
-68.46%
-68.46%
Moderna, Inc.
Moderna, Inc.
-11.5%
19.92%
-1.43%
-63.9%
737.94%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.78%
11.32%
45.17%
82.69%
236.57%
Novo Nordisk A/s
Novo Nordisk A/s
-6.33%
26.68%
64.47%
198.6%
438.18%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.24%
14.68%
37.33%
146.48%
182.87%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc.
NA
NA
NA
-1.93
-0.6
-0.35
NA
2.76
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.55
31.55
1.46
44.35
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.95
45.95
2.36
3.45
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
32.16
32.16
0.53
17.04
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc.
Buy
$147.0M
-68.46%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.9B
737.94%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.9B
236.57%
31.55
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$591.6B
438.18%
45.95
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$128.0B
182.87%
32.16
39.46%

Insights on Vigil Neuroscience, Inc.

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 64.5% return, outperforming this stock by 110.9%

Institutional Holdings

  • Northpond Ventures, LLC

    11.21%
  • Bvf Inc

    4.83%
  • Artal Group S A

    4.82%
  • Sphera Funds Management Ltd.

    4.60%
  • Deep Track Capital, LP

    4.24%
  • 683 Capital Management LLC

    2.65%

Company Information

vigil neuroscience is the world’s first microglia-focused therapeutics company. our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. we are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.

Organization
Vigil Neuroscience, Inc.
Employees
65
CEO
Dr. Ivana Magovcevic-Liebisch J.D., Ph.D.
Industry
Services

FAQs